It is the first ruling in a case challenging “shield laws” intended to protect doctors in states that support abortion rights who send abortion pills to states with bans.

The case could lead to a battle in federal court over whether states that support abortion rights can protect doctors who provide abortion services.

The findings showed the highest mortality occurred among infants who were Black, lived in Southern states or had fetal birth defects.

The case opens a new front in the battle between states that ban abortion and states that support providing abortion anywhere in the country.

The research could further complicate the polarized politics of abortion because the drug in the study is the key ingredient in a pill used for emergency contraception.

By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a study predicts.

Washington State’s program is the first, but other states are expected to try allowing pharmacists to prescribe the pills to counter growing efforts to curtail abortion access.

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.